Announcements Trials

Browse Landscape Eligibility

Clinical Trials

0 trials

Recent Start date Enrollment

Breast Carcinoma In Situ × CTLA-4 Antigen × 90 days × Clear all

Sponsor

Conditions

Melanoma 9 Carcinoma, Renal Cell 6 Neoplasm Metastasis 4 Urinary Bladder Neoplasms 3 Urethral Neoplasms 3 Lung Neoplasms 3 Carcinoma, Non-Small-Cell Lung 3 Urogenital Neoplasms 2 Ureteral Neoplasms 2 Rectal Neoplasms 2 Prostatic Neoplasms 2 Penile Neoplasms 2 Myelodysplastic Syndromes 2 Meningioma 2 Carcinoma, Transitional Cell 2 Carcinoma, Endometrioid 2 Carcinoma, Basal Cell 2 Vulvar Neoplasms 1 Urachal adenocarcinoma 1 Triple Negative Breast Neoplasms 1 Thyroid Neoplasms 1 Squamous Cell Carcinoma of Head and Neck 1 Somatostatinoma 1 Small Cell Lung Carcinoma 1 Seminoma 1 Sarcoma, Kaposi 1 Rare Diseases 1 Pseudomyxoma Peritonei 1 Prostatic Neoplasms, Castration-Resistant 1 Pheochromocytoma 1

Interventions

Specimen Handling 5 Tamoxifen 4 Standard of Care 4 Practice Guidelines as Topic 4 Methods 2 pembrolizumab 1 exemestane 1 Watchful Waiting 1 Telemedicine 1 Starch 1 Sentinel Lymph Node Biopsy 1 Radiotherapy 1 Radiosurgery 1 Radiation Dose Hypofractionation 1 Radiation 1 Observation 1 Magnetic Resonance Spectroscopy 1 Letrozole 1 Genotype 1 Gels 1 Educational Status 1 Early Intervention, Educational 1 Diet Therapy 1 Diet 1 Biopsy 1 Behavior Therapy 1 Anesthesia, General 1 Anastrozole 1 Absorptiometry, Photon 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

No trials found.

Data powered by HemOnc (CC BY 4.0) Colophon ⚡